Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
CCEL Cryo-Cell International
3.990-0.030-0.75%
Close
02/03 16:00 ET
4.170+0.180+4.51%
Post Mkt Price 02/03 17:15 ET
High
4.050
Open
4.020
Turnover
24.85K
Low
3.990
Pre Close
4.020
Volume
6.01K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Cryo-Cell Said in S-1 Filing That It Planned to Offer Senior Notes
Cryo-Cell Said in S-1 Filing That It Planned to Offer Senior Notes
Cryo-Cell Withdraws Form S-1 Filed in April 2022 >CCEL
Cryo-Cell Withdraws Form S-1 Filed in April 2022 >CCEL
Cryo-Cell International (OTCMKTS:CCEL) Stock Passes Below Two Hundred Day Moving Average of $5.34
Cryo-Cell International, Inc. (OTCMKTS:CCEL – Get Rating)'s share price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $5
Cryo-Cell International (OTCMKTS:CCEL) Share Price Passes Below Two Hundred Day Moving Average of $5.62
Cryo-Cell International, Inc. (OTCMKTS:CCEL – Get Rating)'s share price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $5.62 and traded
Cryo-Cell International (OTCMKTS:CCEL) Stock Price Crosses Below 200-Day Moving Average of $5.81
Cryo-Cell International, Inc. (OTCMKTS:CCEL – Get Rating)'s stock price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $5.81 and trade
Cryo-Cell International (OTCMKTS:CCEL) Share Price Crosses Below Two Hundred Day Moving Average of $5.87
Cryo-Cell International, Inc. (OTCMKTS:CCEL – Get Rating)'s share price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $5.87 and traded
Comparing Cryo-Cell International (OTCMKTS:CCEL) & Lisata Therapeutics (NASDAQ:LSTA)
Cryo-Cell International (OTCMKTS:CCEL – Get Rating) and Lisata Therapeutics (NASDAQ:LSTA – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two
Financial Analysis: Cryo-Cell International (OTCMKTS:CCEL) Vs. Lisata Therapeutics (NASDAQ:LSTA)
Cryo-Cell International (OTCMKTS:CCEL – Get Rating) and Lisata Therapeutics (NASDAQ:LSTA – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the tw
Cryo-Cell International, Inc. (OTCMKTS:CCEL) CEO Buys $18,865.00 in Stock
Cryo-Cell International, Inc. (OTCMKTS:CCEL – Get Rating) CEO David Portnoy purchased 3,850 shares of Cryo-Cell International stock in a transaction dated Thursday, November 10th. The stock was acqui
Cryo-Cell International, Inc. (OTCMKTS:CCEL) CEO David Portnoy Purchases 20,000 Shares
Cryo-Cell International, Inc. (OTCMKTS:CCEL – Get Rating) CEO David Portnoy bought 20,000 shares of the company's stock in a transaction that occurred on Tuesday, November 8th. The stock was purchase
Company Overview
More
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Cellular Processing and Cryogenic Storage, and Prepacyte CB. The Cellular Processing and Cryogenic Storage segment focuses on the collection and preservation of umbilical cord blood and tissue stem cells for family use. The Prepacyte CB segment refers to the processing technology used to process umbilical cord blood stem cells. The company was founded in 1989 and is headquartered in Oldsmar, FL.
CEO： --
Market： AMEX
Listing Date： 08/31/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet